BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32733662)

  • 21. Cytogenetic and molecular characteristics and outcomes of adult patients with early T-cell precursor acute lymphoblastic leukemia.
    Yoon JH; Kim HS; Min GJ; Park SS; Park S; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Lee JW; Kim M; Kim Y; Lee S
    Eur J Haematol; 2023 Feb; 110(2):137-148. PubMed ID: 36217591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparative Analysis of Early T-Cell Precursor Lymphoblastic Leukemia/Lymphoma (ETP-ALL/LBL) and Non-ETP-ALL/LBL in a Tertiary Cancer Care Center Based in Western India.
    Saha A; Brahmbhatt B; Rai V; Kakoty S; Sawhney J
    Indian J Hematol Blood Transfus; 2023 Oct; 39(4):699-704. PubMed ID: 37786816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].
    Luo L; Jiao Y; Yang P; Li Y; Huang WY; Ke XY; Zou DH; Jing HM
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):388-394. PubMed ID: 37550188
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
    Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
    Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia.
    Rashkovan M; Albero R; Gianni F; Perez-Duran P; Miller HI; Mackey AL; Paietta EM; Tallman MS; Rowe JM; Litzow MR; Wiernik PH; Luger S; Sulis ML; Soni RK; Ferrando AA
    Cancer Discov; 2022 Mar; 12(3):856-871. PubMed ID: 34711640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick.
    Tarantini F; Cumbo C; Anelli L; Zagaria A; Specchia G; Musto P; Albano F
    Biomark Res; 2021 Dec; 9(1):89. PubMed ID: 34930475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and
    Chen Y; Zhang L; Huang J; Hong X; Zhao J; Wang Z; Zhang K
    Exp Ther Med; 2017 Nov; 14(5):3979-3984. PubMed ID: 29067094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
    Wang M; Zhang C
    PLoS One; 2020; 15(5):e0232520. PubMed ID: 32401815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Necessity of Myeloid Mutational Analysis in Early T-cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL).
    Tariq H; Shetty S
    Turk J Haematol; 2023 Aug; 40(3):227-229. PubMed ID: 37431282
    [No Abstract]   [Full Text] [Related]  

  • 30. [Characteristics and prognosis in adult patients with early T-cell precursor acute lymphoblastic leukemia].
    Gong XY; Wang Y; Liu BC; Wei H; Zhou CL; Lin D; Liu KQ; Wei SN; Gong BF; Zhang GJ; Liu YT; Zhao XL; Li Y; Gu RX; Qiu SW; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2018 Dec; 39(12):977-982. PubMed ID: 30612397
    [No Abstract]   [Full Text] [Related]  

  • 31. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
    Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
    Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
    Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
    Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation.
    Liu S; Cui Q; Dai H; Song B; Cui W; Xue S; Qiu H; Miao M; Jin Z; Li C; Fu C; Wang Y; Sun A; Chen S; Zhu X; Wu D; Tang X
    Transplant Cell Ther; 2021 Jun; 27(6):481.e1-481.e7. PubMed ID: 33785365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.
    Raikar SS; Scarborough JD; Sabnis H; Bergsagel J; Wu D; Cooper TM; Keller FG; Wood BL; Bunting ST
    Pediatr Blood Cancer; 2016 Sep; 63(9):1667-70. PubMed ID: 27145535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Mao J; Xue L; Wang H; Zhu Y; Wang J; Zhao L
    Onco Targets Ther; 2021; 14():3795-3802. PubMed ID: 34168464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report.
    Wang P; Peng X; Deng X; Gao L; Zhang X; Feng Y
    Medicine (Baltimore); 2018 Oct; 97(41):e12743. PubMed ID: 30313079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.
    Neumann M; Coskun E; Fransecky L; Mochmann LH; Bartram I; Sartangi NF; Heesch S; Gökbuget N; Schwartz S; Brandts C; Schlee C; Haas R; Dührsen U; Griesshammer M; Döhner H; Ehninger G; Burmeister T; Blau O; Thiel E; Hoelzer D; Hofmann WK; Baldus CD
    PLoS One; 2013; 8(1):e53190. PubMed ID: 23359050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD).
    Lo Nigro L; Andriano N; Buldini B; Silvestri D; Villa T; Locatelli F; Parasole R; Barisone E; Testi AM; Biondi A; Valsecchi MG; Rizzari C; Conter V; Basso G; Cazzaniga G
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia.
    Zhang Y; Qian JJ; Zhou YL; Huang X; Li JH; Li XY; Li CY; Wang HP; Lou YJ; Meng HT; Yu WJ; Tong HY; Jin J; Zhu HH
    Front Oncol; 2020; 10():1423. PubMed ID: 32974153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.